Firebrick Pharma News
The biotechnology sector continues to attract global attention as smaller pharmaceutical companies develop innovative treatments targeting infectious diseases and unmet medical needs. Among emerging players gaining interest from investors and healthcare observers is Firebrick Pharma, an Australian-based biotechnology company focused on developing nasal spray treatments designed to combat viral infections. Recent Firebrick Pharma news highlights … Read more